Albemarle — Nov 5, 2025 release

• Third quarter cash from operations of $356 million was up 57%, or $128 million ; year-to-date cash from operations of $894 million was also up 29%, or $202 million, due to cost and productivity i mprovements, cash management actions and a customer prepayment received in January. • Reducing full-year 2025 capital expenditures outlook to approximately $600 million. • Expect to achieve positive free cash flow (a) of $300 to $400 million for the full year 2025. • Enhancing full-year outlook considerations; enterprise results are expected to be towards the higher end of the previously published $9/kg scenario ranges given year-to-date financial performance and lithium market pricing and better-than-expected Energy Storage volumes. • On October 27, announced agreements to sell stakes in Ketjen and the Eurecat joint venture for combined pre-tax proceeds of approximately $660 million. “Our team delivered strong third quarter results, with adjusted EBITDA up year-over-year despite lower lithium prices, demonstrating the strength of our business and disciplined execution,” said Kent Masters, Chairman and CEO. “Our successful implementation of cost and productivity improvements and reduced capital expenditures coupled with our recent portfolio management actions underscore our commitment to long-term value and enhanced financial flexibility. We remain confident in our full-year outlook and ability to navigate dynamic markets.” Third Quarter 2025 Results In millions, except per share amounts Q3 2025 Q3 2024 $ Change % Change Net sales $ 1,307.8  $ 1,354.7  $ (46.9) (3.5) % Net loss attributable to Albemarle Corporation $